| mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
-0.033 |
0.9 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
BI-2536 |
FIMM |
pan-cancer |
AAC |
0.014 |
0.9 |
| mRNA |
Bicalutamide |
FIMM |
pan-cancer |
AAC |
-0.018 |
0.9 |
| mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |